The ebb and flow of the NHS waiting list: how do recruitment and admission affect event-based measures of the length of 'time-to-admission'?ARMSTRONG, Paul W.Statistics in medicine. 2002, Vol 21, Num 20, pp 2991-3009, issn 0277-6715, 19 p.Article

Do guidelines influence practice?ARMSTRONG, Paul W.Heart (London 1996). 2003, Vol 89, Num 3, pp 349-352, issn 1355-6037, 4 p.Article

A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction : the WEST (Which Early ST-elevation myocardial infarction Therapy) studyARMSTRONG, Paul W.European heart journal. 2006, Vol 27, Num 13, pp 1530-1538, issn 0195-668X, 9 p.Article

A marriage of enhancement: fibrinolysis and conjunctive therapy : Pharmacotherapy in cardiovascular diseases and vascular interventionsC.WELSH, Robert; ARMSTRONG, Paul W.Thrombosis and haemostasis. 2004, Vol 92, Num 6, pp 1194-1200, issn 0340-6245, 7 p.Article

Fibrinolysis for acute myocardial infarction: Current status and new horizons for pharmacological reperfusion, Part 2ARMSTRONG, Paul W; COLLEN, Désiré.Circulation (New York, N.Y.). 2001, Vol 103, Num 24, pp 2987-2992, issn 0009-7322Article

Fibrinolysis for acute myocardial infarction: Current status and new horizons for pharmacological reperfusion, Part 1ARMSTRONG, Paul W; COLLEN, Désiré.Circulation (New York, N.Y.). 2001, Vol 103, Num 23, pp 2862-2866, issn 0009-7322Article

Fibrinolysis for acute myocardial infarction: The future is here and nowARMSTRONG, Paul W; COLLEN, Désiré; ANTMAN, Elliott et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 20, pp 2533-2537, issn 0009-7322, 5 p.Article

To transfer or not to transfer: Acute myocardial infarction reperfusionPATEL, Manesh R; ARMSTRONG, Paul W.The American heart journal. 2004, Vol 147, Num 4, pp 573-574, issn 0002-8703, 2 p.Article

Prehospital management of acute ST-elevation myocardial infarction: A time for reappraisal in North AmericaWELSH, Robert C; ORNATO, Joseph; ARMSTRONG, Paul W et al.The American heart journal. 2003, Vol 145, Num 1, pp 1-8, issn 0002-8703, 8 p.Article

Progress in the treatment of acute coronary syndromes: A 50-year perspective (1950-2000)THEROUX, Pierre; WILLERSON, James T; ARMSTRONG, Paul W et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 20, pp IV.2-IV.13, issn 0009-7322, NSArticle

Reperfusion Paradox in ST-Segment Elevation Myocardial InfarctionARMSTRONG, Paul W; BODEN, William E.Annals of internal medicine. 2011, Vol 155, Num 6, pp 389-391, issn 0003-4819, 3 p.Article

Bolus fibrinolysis : Risk, benefit, and opportunitiesARMSTRONG, Paul W; GRANGER, Christopher; VAN DE WERF, Frans et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 8, pp 1171-1173, issn 0009-7322Article

Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trialsEZEKOWITZ, Justin A; ARMSTRONG, Paul W; MCALISTER, Finlay A et al.Annals of internal medicine. 2003, Vol 138, Num 6, pp 445-452, issn 0003-4819, 8 p.Article

Aborted myocardial infarction : a new target for reperfusion therapyVERHEUGT, Freek W. A; GERSH, Bernard J; ARMSTRONG, Paul W et al.European heart journal. 2006, Vol 27, Num 8, pp 901-904, issn 0195-668X, 4 p.Article

Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort studyMCALISTER, Finlay A; EZEKOWITZ, Justin; TONELLI, Marcello et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 8, pp 1004-1009, issn 0009-7322, 6 p.Article

Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failureEZEKOWITZ, Justin A; MCALISTER, Finlay A; ARMSTRONG, Paul W et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 2, pp 223-225, issn 0009-7322, 3 p.Article

Do the investigative Sites that take part in a positive clinical trial translate that evidence into practice?MAJUMDAR, Sumit R; CHANG, Wei-Ching; ARMSTRONG, Paul W et al.The American journal of medicine. 2002, Vol 113, Num 2, pp 140-145, issn 0002-9343Article

Usefulness of Spironolactone in a specialized heart failure clinicSLIGL, Wendy; MCALISTER, Finlay A; EZEKOWITZ, Justin et al.The American journal of cardiology. 2004, Vol 94, Num 4, pp 443-447, issn 0002-9149, 5 p.Article

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trialWIVIOTT, Stephen D; WHITE, Harvey D; CLEMMENSEN, Peter et al.Lancet (British edition). 2013, Vol 382, Num 9892, pp 605-613, issn 0140-6736, 9 p.Article

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudyVAN DIEPEN, Sean; NEWBY, L. Kristin; REIST, Craig et al.International journal of cardiology. 2013, Vol 168, Num 3, pp 2127-2133, issn 0167-5273, 7 p.Article

Regional Patterns of Use of a Medical Management Strategy for Patients With Non―ST-Segment Elevation Acute Coronary Syndromes: Insights From the EARLY ACS TrialROE, Matthew T; WHITE, Jennifer A; MAGNUS OHMAN, E et al.Circulation. Cardiovascular quality and outcomes (Print). 2012, Vol 5, Num 2, pp 205-213, issn 1941-7713, 9 p.Article

Evaluating Research in Cardiovascular Medicine: Citation Counts Are Not SufficientMCALISTER, Finlay A; LAWSON, Fiona M. E; GOOD, A. Heather et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 9, pp 1038-1043, issn 0009-7322, 6 p.Article

The future of clinical trials in secondary prevention after acute coronary syndromesBUENO, Hector; ARMSTRONG, Paul W; GABRIEL STEG, Ph et al.European heart journal. 2011, Vol 32, Num 13, pp 1583-1589, issn 0195-668X, 7 p.Article

Mode of hospital presentation in patients with non-ST-elevation myocardial infarction: Implications for strategic managementTYMCHAK, Wayne; ARMSTRONG, Paul W; WESTERHOUT, Cynthia M et al.The American heart journal. 2011, Vol 162, Num 3, pp 436-443, issn 0002-8703, 8 p.Article

Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysisSINNAEVE, Peter R; EZEKOWITZ, Justin A; BOGAERTS, Kris et al.European heart journal. 2009, Vol 30, Num 18, pp 2213-2219, issn 0195-668X, 7 p.Article